Internal Medicine Meeting Recordings
Expert clinician-educators will discuss the diagnosis of prediabetes and diabetes, including atypical forms of diabetes in adults. Faculty will review the role of lifestyle interventions as well as appropriate indications and practical use of weight loss medications. The growing role of diabetes technology will be addressed and the risks and benefits of new insulin and noninsulin pharmacologic therapies will also be presented. The role of diabetes medications, cholesterol-lowering agents, and blood pressure control to reduce cardiometabolic risk will be thoroughly discussed.
This collection of virtual lectures will cover:
- current guidelines for the management of patients with diabetes and prediabetes
- guidance on the evaluation, classification, and treatment of diabetes, including less common atypical forms of diabetes
- new insulin products and diabetes technology (including new pens, pumps, and sensors) available for patients with type 1 and 2 diabetes.
- the rapidly expanding role of noninsulin therapeutics in the management of type 2 diabetes.
- the role of nutrition and medication use for weight management in patients with obesity and diabetes.
- the prevention and treatment of cardiovascular disease in patients with diabetes.
Course Director:
Irl B. Hirsch, MD, MACP
Professor of Medicine, University of Washington School of Medicine, University of Washington, Seattle, WA
CME/MOC:
Up to 7
AMA PRA Category 1 Credits ™ and MOC Points
Expires June 02, 2027
active
Cost:
Discounted to Members
Format:
Video Recordings
Product:
Internal Medicine Meeting Recordings
ACP's Internal Medicine Meeting Recording packages include video and slide presentations from a curated selection of popular and highly rated sessions delivered during or derived from the ACP Internal Medicine Meeting. Trusted, timely content in general internal medicine and the subspecialties is presented by expert faculty; CME and MOC available.
Disclosures
The following individual(s) disclosed relevant financial relationships with ACCME-defined ineligible companies. No other individuals in control of content have anything to disclose. All relevant financial relationships have been mitigated.
Grazia Aleppo, MD, FACP
Research Grant/Contract: Dexcom Inc., Fractyl, MannKind Corporation, Insulet Corporation, Tandem Diabetes Care Inc.
Consultantship: Dexcom Inc., Insulet Corporation
Poster Presentation: Eli Lilly and Company
Irl Hirsch, MD, MACP
Research Grant/Contract: Dexcom Inc., Insulet Corporation
Consultantship: Abbott Diabetes Care, Gwave, Roche Diabetes Care Inc.
Janet McGill, MD, FACP
Research Grant/Contract: JDRF, Novo Nordisk
Consultantship: Bayer Healthcare, MannKind Corporation
Savitha Subramanian, MD
Consultantship: Abbott Diabetes Care
Carol Wysham, MD, FACP
Research Grant/Contract: Bayer HealthCare Pharmaceuticals Inc., Eli Lilly and Company
Consultantship: Abbott Laboratories, Biomea
Accreditation
The American College of Physicians (ACP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The ACP designates this enduring material for a maximum of 7 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 7 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Release Date: 6/3/2024
End Date: 6/2/2027